Send me a link:

*Text messaging rates may apply.

 Dow Down 1.04% Nasdaq Down 1.56%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
31.32 Down 0.56(1.76%) 11:12AM EDT - Nasdaq Real Time Price
Prev Close:31.88
Open:31.57
Bid:31.12 x 200
Ask:31.17 x 200
1y Target Est:43.56
Beta:1.63
Next Earnings Date: 4-Aug-14ISIS Earnings announcement
Day's Range:31.11 - 31.87
52wk Range:22.25 - 62.66
Volume:464,470
Avg Vol (3m):2,698,460
Market Cap:3.68B
P/E (ttm):N/A
EPS (ttm):-0.79
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ISIS

Comparison

Symbol% ChgMkt Cap
ISISDown 1.76%3.68B
ENZDown 3.62%209.93M
GILDDown 1.90%140.41B
SRPTDown 5.06%885.56M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):28.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.71
Quarterly EPS Est (Jun-14) :-0.12
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-1.84

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback